{"id":25823,"date":"2024-05-31T11:08:52","date_gmt":"2024-05-31T09:08:52","guid":{"rendered":"https:\/\/idibell.cat\/?p=25823"},"modified":"2024-06-03T17:17:04","modified_gmt":"2024-06-03T15:17:04","slug":"fundacio-hna-premia-un-projecte-de-la-dra-povedano-sobre-biomarcadors-per-a-la-deteccio-de-lela","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2024\/05\/fundacio-hna-premia-un-projecte-de-la-dra-povedano-sobre-biomarcadors-per-a-la-deteccio-de-lela\/","title":{"rendered":"La Fundaci\u00f3 hna premia un projecte de la Dra Povedano sobre biomarcadors per a la detecci\u00f3 de l’ELA"},"content":{"rendered":"

La quarta edici\u00f3 del Premi Recerca Cient\u00edfica de Salut<\/a> de Fundaci\u00f3 hna s’ha tancat amb la cerim\u00f2nia de lliurament de premis als projectes guardonats. El jurat va atorgar el primer premi, dotat amb 100.000 euros, al projecte “Caracteritzaci\u00f3 de les vies moleculars subjacents en l’espectre patol\u00f2gic ELA-DFT en base a l’expressi\u00f3 fenot\u00edpica: nous biomarcadors”, liderat per M\u00f3nica Povedano Panad\u00e9s<\/a>, de l’Institut d’Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) i coordinadora de la Unitat Funcional de Malaltia de Motoneurona del Servei de Neurologia de l’Hospital Universitari de Bellvitge (HUB). El segon premi, dotat amb 50.000 euros, ha estat per a Ivonne Jeric\u00f3 Pascual, de la Fundaci\u00f3 Miguel Servet (FMS) -Navarrabiomed.<\/p>\n

 <\/p>\n

Ahir, a Madrid, va tenir lloc l’esdeveniment en qu\u00e8 van participar les investigadores guardonades, Povedano Panad\u00e9s i Jeric\u00f3 Pascual, les quals van agrair el reconeixement i van valorar la contribuci\u00f3 de Fundaci\u00f3 hna a l’avan\u00e7 de la recerca; aix\u00ed com representants de la fundaci\u00f3. <\/em>Durant l’acte es va projectar un v\u00eddeo amb testimonis de persones diagnosticades d’ELA agraint l’impuls a la investigaci\u00f3 d’aquesta malaltia.<\/p>\n

 <\/p>\n

El projecte t\u00e9 una durada de dos anys i pret\u00e9n caracteritzar fenot\u00edpicament els pacients, per\u00f2 tamb\u00e9 endofenot\u00edpicament mitjan\u00e7ant biomarcadors \u201cque ens ajudin a estratificar i poder arribar realment a una medicina personalitzada. Els biomarcadors que trobem els validarem amb models animals per tal que siguin \u00fatils per als pacients\u201d, afirma la Dra. M\u00f2nica Povedano. Afegeix que aquesta estratificaci\u00f3 \u00e9s important \u201cperqu\u00e8 despr\u00e9s del temps que portem amb assajos cl\u00ednics sense resultats positius, no creiem que les dianes terap\u00e8utiques siguin err\u00f2nies, sin\u00f3 que probablement no estem categoritzant b\u00e9 els pacients\u201d.<\/p>\n

 <\/p>\n

Aquesta edici\u00f3 del Premi Recerca Cient\u00edfica de Salut de Fundaci\u00f3 hna havia rebut 10 candidatures. La convocat\u00f2ria tenia com a objecte la investigaci\u00f3 sobre biomarcadors per a la detecci\u00f3 primerenca de l’Esclerosi Lateral Amiotr\u00f2fica (ELA). Ja en la passada edici\u00f3 el Premi es va centrar en biomarcadors, en aquella ocasi\u00f3 de la malaltia d’Alzheimer. Els biomarcadors s\u00f3n subst\u00e0ncies que es poden mesurar, i amb aix\u00f2 ser utilitzades com a indicadors d’un proc\u00e9s biol\u00f2gic (normal, patog\u00e8nic o de resposta a un tractament).<\/p>\n

 <\/p>\n

Aquesta \u00e9s la segona ocasi\u00f3 en qu\u00e8 el Premi d’Investigaci\u00f3 Cient\u00edfica de Salut<\/a> de Fundaci\u00f3 hna se centra en l’Esclerosi Lateral Amiotr\u00f2fica, malaltia que ja es va abordar en la primera convocat\u00f2ria dels guardons, llan\u00e7ada el 2020 i on \u00e9s necess\u00e0ria una cont\u00ednua investigaci\u00f3 per aconseguir combatre-la. Aquests premis s’emmarquen en els objectius de Fundaci\u00f3 hna, entre els quals hi ha la promoci\u00f3 de la recerca en els camps de la medicina i la salut.<\/p>\n

 <\/p>\n

 <\/p>\n

L\u2019Institut d’Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) \u00e9s un centre de recerca en biomedicina creat l\u2019any 2004. Est\u00e0 participat per l’Hospital Universitari de Bellvitge i l\u2019Hospital de Viladecans de l’Institut Catal\u00e0 de la Salut, l’Institut Catal\u00e0 d’Oncologia, la Universitat de Barcelona i l\u2019Ajuntament de l\u2019Hospitalet de Llobregat.<\/em><\/p>\n

L\u2019IDIBELL \u00e9s membre del Campus d’Excel\u00b7l\u00e8ncia Internacional de la Universitat de Barcelona HUBc i forma part de la instituci\u00f3 CERCA de la Generalitat de Catalunya. L’any 2009 es va convertir en un dels cinc primers centres d\u2019investigaci\u00f3 espanyols acreditats com a institut d\u2019investigaci\u00f3 sanit\u00e0ria per l\u2019Instituto de Salud Carlos III. A m\u00e9s, forma part del programa \u201cHR Excellence in Research\u201d de la Uni\u00f3 Europea i \u00e9s membre de EATRIS i REGIC. Des de l\u2019any 2018, l\u2019IDIBELL \u00e9s un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

Ahir es va celebrar la cerim\u00f2nia de lliurament de la quarta edici\u00f3 dels Premis Recerca Cient\u00edfica de Salut de Fundaci\u00f3 hna, que enguany s’ha centrat en l’Esclerosi Lateral Amiotr\u00f2fica (ELA), una malaltia neurodegenerativa sense cura i amb poques eines diagn\u00f2stiques.<\/p>\n","protected":false},"author":8,"featured_media":25824,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[416,340,457],"tags":[],"class_list":["post-25823","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-malalties-neurologiques-i-neurogenetica","category-neurociencies","category-p-de-neurociencies"],"publishpress_future_action":{"enabled":false,"date":"2025-01-29 05:07:14","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/25823","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=25823"}],"version-history":[{"count":4,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/25823\/revisions"}],"predecessor-version":[{"id":25851,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/25823\/revisions\/25851"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/25824"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=25823"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=25823"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=25823"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}